Search Orphan Drug Designations and Approvals
-
| Generic Name: | Chimeric (human-murine) G250 IgG monoclonal antibody |
|---|---|
| Date Designated: | 07/24/2000 |
| Orphan Designation: | Treatment of renal cell carcinoma. |
| Orphan Designation Status: | Designated/Withdrawn |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Wilex Biotechnology GmbH Grillparzerstrasse 10B 81675 Munich Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
-
